 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2015, vol. 21, issue 4
Subject Area: Medicine - Pediatrics
Pages: 901-907
DOI: 10.5272/jimab.2015214.901
Published online: 10 November 2015
J of IMAB 2015 Oct-Dec;21(4):901-907
MARKERS OF BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS.
Bojana Naydenova- Stoeva
,
Pediatric Clinic UMHAT “Alexandrovska”, Sofia, Bulgaria.
ABSTRACT:
Aim: Some scientific studies show decreased bone mineral density and increased fracture frequency in patients with cystic fibrosis. The mechanism for early bone loss in CF patients are multifactorial: chronic pulmonary inflammation, malnutrition, reducer physical activity, delayed pubertal maturation. The aim of this study was to assess bone metabolism markers in patients with cystic fibrosis and compare them with these in healthy controls.
Material and Methods: We examined 44 patients with cystic fibrosis with average age 14,7 years. The control group consist 43 healthy controls with average age 13,8 years. The levels of bone markers- N Mid Osteocalcin and β Cross Laps in the serum were examined by electro-chemiluminescence method- ECLIA; serum alkaline phosphatase (AP)- kinetic method; common and ionized calcium- atomic-absorption method. The statistical processing of data is made with SPSS programme- version 16.0.
Results: It was established a statistically significant and increased levels of the markers of bone formation in patients, probably as a compensative reaction of the organism to the increased bone resorption (comparing the median levels of β Cross Laps in the two groups). This difference stays constant when only men from the two groups were compared, while there is no such difference between women. Only in the group of patients-men there is a significant evaluated levels of β Cross Laps, compared with the mediate levels in patients-women and less increased N Mid Osteocalcine and AP. Increasing the age of patients, the levels of the investigated markers i.e. N Mid Osteocalcine decrease. This is not found out in the group of the controls. N Mid Osteocalcine is in positive relation with AP in the two groups, and that confirms the fact that the growth of AP returns for its bone fraction. The increase of β Cross Laps is related with the increase of N Mid Osteocalcine.
Conclusion: In patients with cystic fibrosis changes in the profile of bone metabolism were observed. The patients should be under a comprehensive medical and nutritional care in order to achieve their optimal peak bone mass.
Key words: cystic fibrosis, bone markers,
- Download FULL TEXT /PDF 504 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Naydenova- Stoeva B. Markers of bone metabolism in patients with cystic fibrosis. J of IMAB. 2015 Oct-Dec;21(4):901-907. doi: http://dx.doi.org/10.5272/jimab.2015214.901
Correspondence to: Dr. Bojana Naydenova- Stoeva, Pediatric Clinic UMHAT “Alexandrovska”; 1, St. Georgi Sofiysky Blvd., 1431 Sofia; E-mail: jani_2005@mail.bg
REFERENCES:
1. Galeva I. [Clinical and genetic characteristics of cystic fibrosis in early childhood]. Dissertation, Sofia, 2000. [in Bulgarian]
2. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boylw MP, Elkin SL, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2005 Mar;90(3):1888-96. [PubMed] [CrossRef]
3. Elkin SL, Faimey A, Burnett S, Kemp M, Kyd P, Burgess J, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross sectional study. Osteoporos Int. 2001; 12(5):366-72. [PubMed]
4. Sheikh S, Gemma S, Patel A. Factors associated with low bone mineral density in patients with cystic fibrosis. J Bone Miner Metab. 2015 Mar;33(2):180-5. [PubMed] [CrossRef]
5. Donadio MV, Souza GC, Tiecher G, Heinzmana-Fiho JP, Paim TF, Hommerding PX, et al. Bone mineral density, pulmonary function, chronological age and age at diagnosis in children and adolescents with cystic fibrosis. J Pediatr (Rio J). 2013 Mar-Apr;89(2):151-7. [PubMed] [CrossRef]
6. Rossini M, Del Marco A, Dal Santo F, Gatti D, Braqqion C, James G, et al. Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone. 2004 Sep;35(3):771-6. [PubMed] [CrossRef]
7. Aris RM, Renner JB, Winders AD, Buell HE, Riqqs DB, Lester GE, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med. 1998 Feb;128(3):186-93. [PubMed] [CrossRef]
8. Neri AS, Lori I, Festini F, Masi L, Brandi ML, Galici V, et al. Bone mineral density in cystic fibrosis patients under the age of 18 years. Minerva Pediatr. 2008 Apr;60(2):147-54. [PubMed]
9. Florescu L, Paduraru DT, Mindres DE, Temneanu OR, Petzariu FD, Matei MC, et al. Epidemiological evaluation regarding the role of cystic fibrosis as a risk factor for child malnutrition. Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):450-6. [PubMed].
Received: 23 September 2015
Published online: 10 November 2015